C1.7 Antigen expression on CD8+ T cells is activation dependent: Increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing disease

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7563-7568

  Peritt, David ^a,b   Sesok Pizzini, Deborah A ^a   Schretzenmair, Richard ^a   Macgregor, Rob R ^a   Valiante, Nicholas M ^a,c   Tu, Xin ^a   Trinchieri, Giorgio ^a,d   Kamoun, Malek ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTOCOR INC   (United States)

^c Istituto Ricerche Immunobiologiche   (Italy)

^d WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MEDIATOR RELEASE; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MUROMONAB-CD3; T-LYMPHOCYTE SUBSETS;

EID: 0033564949     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Valiante, N., and G. Trinchieri. 1993. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178:1397.
2. + cytotoxic T lymphocytes involved in clinical heart rejection. Transplantation 66:135.
3. + T lymphocytes that express cytotoxicity-associated molecules and are committed to produce interferon-γ and tumor necrosis factor-α. J. Infect. Dis. 178:1158.
4. + T cells in HIV disease and following in vitro activation. In: Leucocyte Typing V, Vol. 1. S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder, and R. F. Todd, eds. Oxford University Press, Oxford, p. 446.
5. Brown, M. H., K. Boles, P. Anton van der Merwe, V. Kumar, P. A. Mathew, and A. N. Barclay. 1998. 2B4, the natural killer and T cell immunoglobulin super-family surface protein, is a ligand for CD48. J. Exp. Med. 188:2083.
6. + subsets in different stages of HIV infection. Pathobiology 65:91.
7. + T cell populations in HIV disease and in anti-HIV immunity. Clin. Exp. Immunol. 92:93.
8. + from HIV-infected patients: a new early marker for disease progression? AIDS Res. Hum. Retroviruses 11:1327.
9. + in HIV-infected patients are predominantly CD11a bright. AIDS 9:653.
10. + T lymphocytes in haemophiliac individuals with HIV-1 infection. Clin. Exp. Immunol. 93:51.
11. Aldhous, M. C., K. C. Watret, J. Y. Mok, A. G. Bird, and K. S. Froebel. 1994. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin. Exp. Immunol. 97:61.
12. Peakman, M., M. Mahalingam, A. Pozniak, T. J. McManus, A. N. Phillips, and D. Vergani. 1995. Markers of immune cell activation and disease progression: cell activation in HIV disease. Adv. Exp. Med. Biol. 374:17.
13. + T lymphocytes. AIDS 9:561.
14. + peripheral blood leukocytes mediating cytotoxic T-lymphocyte activity during human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 90:9427.
15. Hemler, M. E. 1990. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:365.
16. + T cells. Immunol. Today 17:217.
17. + T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquired Immune Defic. Syndr. 6:904.
18. Morimoto, C., C. E. Rudd, N. L. Letvin, and S. F. Schlossman. 1987. A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells. Nature 330:479.
19. Anonymous. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Wkly. Rep. 41:1.
20. Anonymous. 1993. From the Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 269:729.
21. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
22. + T cells. J. Exp. Med. 186:1407.
23. Swain, S. L., and L. M. Bradley. 1992. Helper T cell memory: more questions than answers. Semin. Immunol. 4:59.
24. + T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J. Immunol. 150:429.
25. + T cells. Cell. Immunol. 139:176.
26. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353.
27. + T lymphocytes. J. Immunol. 146:3242.
28. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791.
29. + counterparts. J. Immunol. 156:3587.
30. Berthou, C., S. Legros-Maida, A. Soulie, A. Wargnier, J. Guillet, C. Rabian, E. Gluckman, and M. Sasportes. 1995. Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood 85:1540.
31. + T cells from HIV-infected subjects. Clin. Exp. Immunol. 100:425.
32. - T lymphocytes: antigenic and functional properties. J. Immunol. 150:1147.
33. - lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J. Virol. 70:2022.
34. + T lymphocytes during HIV-1 infection. J. Acquired Immune Defic. Syndr. 7:245.
35. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829.
36. Combadiere, C., S. K. Ahuja, H. L. Tiffany, and P. M. Murphy. 1996. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1α, MIP-1β, and RANTES. J. Leukocyte Biol. 60:147.
37. Bouscarat, F., M. Levacher-Clergeot, M. C. Dazza, K. W. Strauss, P. M. Girard, C. Ruggeri, and M. Sinet. 1996. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 12:17.
38. Roos, M. T., N. A. de Leeuw, F. A. Claessen, H. G. Huisman, N. A. Kootstra, L. Meyaard, P. T. Schellekens, H. Schuitemaker, and F. Miedema. 1994. Viro-immunological studies in acute HIV-1 infection. AIDS 8:1533.
39. Roederer, M., J. G. Dubs, M. T. Anderson, P. A. Raju, L. A. Herzenberg, and L. A. Herzenberg. 1995. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95:2061.
40. Rabin, R. L., M. Roederer, Y. Maldonado, A. Petru, L. A. Herzenberg, and L. A. Herzenberg. 1995. Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J. Clin. Invest. 95:2054.